NCI awards $1.5M for development of companion Dx test for melanoma

09/26/2013 | GenomeWeb Daily News (free registration)

The National Cancer Institute has awarded BioMarker Strategies a $1.5 million grant to advance the development of its PathMap test, a companion diagnostic assay for melanoma. The company also will use the grant to finance its efforts to validate the assay in human clinical specimens.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care